Circulating tumor cells from a 4-dimensional lung cancer model are resistant to cisplatin

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 3, 2014, Pages 1056-1064

  Vishnoi, Monika ^a   Mishra, Dhruva K ^a   Thrall, Michael J ^a   Kurie, Jonathan M ^b   Kim, Min P ^a,c  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GELATINASE A;

CANCER SIZE; CELL VIABILITY; CIRCULATING TUMOR CELL; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CANCER CELL LINE; LUNG NODULE; PETRI DISH; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOREACTORS; CELL LINE, TUMOR; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; NEOPLASTIC CELLS, CIRCULATING; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TISSUE SCAFFOLDS;

EID: 84908518413     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.05.059     Document Type: Conference Paper

References (19)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. F. Petrelli, A. Coinu, M. Cabiddu, M. Ghilardi, M. Ardine, and S. Barni Platinum rechallenge in patients with advanced NSCLC: a pooled analysis Lung Cancer 81 2013 337 342
4. G.L. Shaw, A.F. Gazdar, R. Phelps, S.M. Steinberg, R.I. Linnoila, and B.E. Johnson et al. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer J Cell Biochem Suppl 24 1996 173 185
5. R.A. Vescio, K.M. Connors, T. Kubota, and R.M. Hoffman Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice Proc Natl Acad Sci U S A 88 1991 5163 5166
6. H.C. Ott, B. Clippinger, C. Conrad, C. Schuetz, I. Pomerantseva, and L. Ikonomou et al. Regeneration and orthotopic transplantation of a bioartificial lung Nat Med 16 2010 927 933
7. D.K. Mishra, M.J. Thrall, B.N. Baird, H.C. Ott, S.H. Blackmon, and J.M. Kurie et al. Human lung cancer cells grown on acellular rat lung matrix create perfusable tumor nodules Ann Thorac Surg 93 2012 1075 1081
8. D.K. Mishra, J.H. Sakamoto, M.J. Thrall, B.N. Baird, S.H. Blackmon, and M. Ferrari et al. Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture PLoS one 7 2012 e45308
9. D.K. Mishra, C.J. Creighton, Y. Zhang, D.L. Gibbons, J.M. Kurie, and M.P. Kim Gene expression profile of A549 cells from tissue of 4D model predicts poor prognosis in lung cancer patients Int J Cancer 134 2014 789 798
10. G. Giaccone, J. Battey, A.F. Gazdar, H. Oie, M. Draoui, and T.W. Moody Neuromedin B is present in lung cancer cell lines Cancer Res 52 1992 2732s 2736s
11. D.J. Giard, S.A. Aaronson, G.J. Todaro, P. Arnstein, J.H. Kersey, and H. Dosik et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors J Natl Cancer Inst 51 1973 1417 1423
12. L. Girard, S. Zochbauer-Muller, A.K. Virmani, A.F. Gazdar, and J.D. Minna Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering Cancer Res 60 2000 4894 4906
13. K.J. Himmelstein, T.F. Patton, R.J. Belt, S. Taylor, A.J. Repta, and L.A. Sternson Clinical kinetics on intact cisplatin and some related species Clin Pharmacol Ther 29 1981 658 664
14. K.N. Kashkin, E.A. Musatkina, A.V. Komelkov, E.A. Tonevitsky, D.A. Sakharov, and T.V. Vinogradova et al. Genes potentially associated with cisplatin resistance of lung cancer cells Dokl Biochem Biophys 438 2011 147 150
15. H. Shen, R.E. Perez, B. Davaadelger, and C.G. Maki Two 4N cell-cycle arrests contribute to cisplatin-resistance PLoS one 8 2013 e59848
16. R.O. Dillman, J. Herndon, S.L. Seagren, W.L. Eaton Jr., and M.R. Green Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
17. N. Ortega, and Z. Werb New functional roles for non-collagenous domains of basement membrane collagens J Cell Sci 115 2002 4201 4214
18. R. Ali-Labib, M.L. Louka, I.H. Galal, and M. Tarek Evaluation of matrix metalloproteinase-2 in lung cancer Proteomics Clin Appl 8 2014 251 257
19. C.B. Guo, S. Wang, C. Deng, D.L. Zhang, F.L. Wang, and X.Q. Jin Relationship between matrix metalloproteinase 2 and lung cancer progression Mol Diagn Ther 11 2007 183 192